Scribe Therapeutics Inc. Common Stock (SCTX) — Financial Flexibility Index
Scribe Therapeutics Inc. Common Stock (SCTX) has a Financial Flexibility Index of -0.03x as of March 2026. Free cash flow of $-7.54 Million (operating CF $-7.55 Million minus capex $17.00K) represents 0% of total liabilities ($223.95 Million). For the full cash flow conversion analysis, see cash efficiency ratio of Scribe Therapeutics Inc. Common Stock.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Scribe Therapeutics Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Scribe Therapeutics Inc. Common Stock across 2 annual periods. Also explore Scribe Therapeutics Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Annual Financial Flexibility Index for Scribe Therapeutics Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Scribe Therapeutics Inc. Common Stock. Explore Scribe Therapeutics Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.20x | $-43.94 Million | $-45.21 Million | $221.64 Million | ▼ -14.7% |
| 2024 | -0.17x | $-43.89 Million | $-45.23 Million | $253.83 Million | — |